High Intensity Focused Ultrasound Market Size & Growth Forecast 2027–2036, By Segments (Application, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
High Intensity Focused Ultrasound Market size stood at USD 1.5 billion in 2026 and is predicted to grow at a 6.84% CAGR from 2027 to 2036, reaching USD 2.91 billion by 2036. The industry revenue for 2027 is calculated at USD 1.59 billion.
Get more details on this report
Request Free Sample ReportHigh Intensity Focused Ultrasound Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 31.83% share due to advanced healthcare infrastructure, established adoption of minimally invasive therapies, and strong integration of image-guided treatment technologies into clinical practice.
- Asia Pacific is growing at an 8.25% CAGR, supported by rising access to non-invasive treatments and increasing investment in modern therapeutic platforms across high-volume hospital environments.
Segment Momentum
- Dermatology held 22.25% share in 2026 due to steady demand for non-invasive skin and aesthetic treatments, short recovery time procedures, and integration into routine outpatient clinical workflows.
- Uterine fibroids is the fastest-growing application as patients and physicians increasingly prefer non-invasive alternatives that preserve the uterus and reduce recovery time compared to conventional surgical procedures.
Market Expansion Drivers
- Rising cancer prevalence increasing adoption of minimally invasive HIFU tumor ablation procedures.
- Expanding cosmetic and neurological applications broadening commercial use of precision ultrasound therapies.
- AI-integrated HIFU platforms improving treatment customization and procedural accuracy across clinical settings.
Leading Market Participants
- Key players in the high intensity focused ultrasound market include EDAP TMS S.A. (France), Sonablate Corp. (United States), Chongqing Haifu Medical Technology Co., Ltd. (China), Theraclion SA (France), Verasonics, Inc. (United States), ALPINION MEDICAL SYSTEMS Co., Ltd. (South Korea), Profound Medical Corp. (Canada), Insightec Ltd. (Israel), ULTRAISER SAS (France).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.5 billion
- 2027 Estimated Market Size: USD 1.59 billion.
- Projected Market Size: USD 2.91 billion by 2036
- Growth Forecast: 6.84% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Dermatology (Application) | Hospitals (End Use)
- Emerging Opportunity Segment: Uterine Fibroids (Application) | Hospitals (End Use)
Market Growth Drivers and Industry Trends
Rising cancer prevalence increasing adoption of minimally invasive HIFU tumor ablation procedures
The increasing incidence of cancer is creating greater demand for treatment options that can reduce procedural invasiveness, supporting growth in the high intensity focused ultrasound market through wider use of HIFU for tumor ablation. HIFU can concentrate acoustic energy on targeted tissue without requiring conventional surgical incisions, offering potential benefits such as reduced tissue disruption, shorter recovery periods, and lower procedural burden for appropriately selected patients. As healthcare providers seek alternatives that can complement or reduce reliance on invasive interventions, the ability to precisely target tumors while preserving surrounding structures is increasing clinical interest in focused ultrasound-based treatment approaches.
Expanding cosmetic and neurological applications broadening commercial use of precision ultrasound therapies
Beyond oncology, the high intensity focused ultrasound market is gaining broader application potential as focused ultrasound technologies are adopted across cosmetic and neurological procedures requiring localized and controlled energy delivery. In aesthetic medicine, HIFU can be used to deliver focused energy to selected tissue layers for non-invasive skin tightening and related treatments, while neurological applications leverage its precision for addressing targeted brain regions without conventional open surgery. The expansion of these use cases is increasing the addressable clinical and commercial landscape for focused ultrasound systems, particularly where patients and providers value procedures that offer targeted treatment with limited physical disruption.
AI-integrated HIFU platforms improving treatment customization and procedural accuracy across clinical settings
Integration of artificial intelligence into HIFU systems is enhancing the ability to analyze patient-specific imaging and treatment parameters, which will propel the high intensity focused ultrasound market by supporting more individualized procedures. AI-assisted platforms can help clinicians identify treatment targets, optimize energy delivery, monitor tissue responses, and adjust procedural parameters based on anatomical characteristics and treatment objectives. Such capabilities are particularly relevant in procedures where accurate targeting and controlled thermal effects are essential, while the combination of imaging, automated analysis, and treatment guidance can support more consistent workflows across specialized clinical environments.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising cancer prevalence increasing adoption of minimally invasive HIFU tumor ablation procedures | 1.90% | High | North America, Asia Pacific | High | Near Term |
| Expanding cosmetic and neurological applications broadening commercial use of precision ultrasound therapies | 1.60% | Moderate | Asia Pacific, Europe | High | Mid Term |
| AI-integrated HIFU platforms improving treatment customization and procedural accuracy across clinical settings | 1.30% | Moderate | North America, Europe | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the high intensity focused ultrasound market with a 31.83% share in 2026, supported by advanced healthcare infrastructure, strong clinical research capabilities, and increasing adoption of non-invasive treatment technologies. The region’s healthcare systems are placing greater emphasis on procedures that can reduce surgical intervention, recovery requirements, and treatment-related burden, creating favorable conditions for focused ultrasound applications. Continued investment in medical technology and growing interest in image-guided therapeutic procedures are also supporting the integration of this technology across specialized clinical settings.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region for the high intensity focused ultrasound market, driven by expanding healthcare infrastructure, rising investments in advanced medical technologies, and increasing demand for minimally invasive treatment options. Growing healthcare access and the modernization of hospitals are creating opportunities for the adoption of image-guided therapeutic platforms. In addition, increasing awareness of non-invasive treatment approaches and broader efforts to improve specialized care capabilities are encouraging healthcare providers to incorporate focused ultrasound technologies into clinical practice.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Clinical IntegrationGermany emphasizes controlled clinical adoption of high intensity focused ultrasound within specialized treatment centers. Manufacturers prioritize regulatory compliance, imaging accuracy, and integration with established hospital treatment protocols.
France 🇫🇷
Targeted Therapy ExpansionFrance is expanding use of high intensity focused ultrasound in targeted treatment protocols across oncology and fibroid management. Providers focus on clinical collaboration, treatment accuracy, and alignment with public healthcare frameworks.
Italy 🇮🇹
Specialized Treatment CentersItaly’s adoption of high intensity focused ultrasound is concentrated in specialized medical centers focusing on non-invasive therapies. Providers emphasize equipment accessibility, procedural efficiency, and integration with existing hospital infrastructure.
Japan 🇯🇵
Advanced Therapeutic InnovationJapan’s high intensity focused ultrasound market is supported by strong adoption in precision oncology and neurology applications. Providers focus on compact system design and alignment with high standards of clinical imaging and treatment precision.
South Korea 🇰🇷
Hospital Technology AdoptionSouth Korea integrates high intensity focused ultrasound into advanced hospital systems focused on minimally invasive therapies. Companies emphasize device efficiency, clinician training, and integration with digital diagnostic imaging platforms.
United States 🇺🇸
Non-Invasive Therapeutics ExpansionIn the U.S., high intensity focused ultrasound is increasingly integrated into minimally invasive treatment pathways across oncology and gynecology. Providers focus on advanced imaging guidance, clinical validation, and hospital system adoption of precision therapeutic platforms.
Segment Leadership and Growth Trends
High Intensity Focused Ultrasound Market Share (%), by Application, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportApplication Segment Analysis: Dermatology (Largest Segment) vs Uterine Fibroids (Fastest-Growing Segment)
Dermatology accounted for 22.25% of the high intensity focused ultrasound market in 2026, supported by the use of focused ultrasound technologies in non-invasive and minimally invasive aesthetic and therapeutic procedures. Demand is being reinforced by growing interest in treatments that can target specific tissue areas without conventional surgical intervention, particularly where reduced recovery requirements and precision are valued. The uterine fibroids segment is expanding more rapidly as clinicians and patients increasingly consider non-invasive approaches for managing symptomatic fibroids. Focused ultrasound can provide targeted tissue ablation while reducing reliance on invasive procedures, supporting its growing relevance within women's health and gynecological treatment pathways.
End Use Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)
Hospitals led the high intensity focused ultrasound market and also represented the fastest-growing end-use segment in 2026, reflecting their ability to provide specialized clinical infrastructure, multidisciplinary expertise, and advanced imaging and treatment capabilities. Hospital-based facilities are well positioned to integrate focused ultrasound into established diagnostic and therapeutic workflows while managing complex patient cases that require coordinated care. Increasing adoption of non-invasive treatment approaches, investments in advanced medical technologies, and the availability of specialized clinical personnel are reinforcing the role of hospitals as key settings for the broader deployment of high intensity focused ultrasound systems.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Application | Uterine Fibroids, Prostate Cancer, Essential Tremor, Dermatology, Breast Cancer, Glaucoma, Backpain, Facetogenic, Others | Dermatology | Uterine Fibroids |
| End Use | Hospitals, Imaging Centers , Others | Hospitals | Hospitals |
Competitive Landscape and Market Positioning
Top players in the high intensity focused ultrasound market:
1. EDAP TMS S.A. (France)
2. Sonablate Corp. (United States)
3. Chongqing Haifu Medical Technology Co. Ltd. (China)
4. Theraclion SA (France)
5. Verasonics Inc. (United States)
6. ALPINION MEDICAL SYSTEMS Co. Ltd. (South Korea)
7. Profound Medical Corp. (Canada)
8. Insightec Ltd. (Israel)
9. ULTRAISER SAS (France)
The high intensity focused ultrasound market is witnessing strong innovation activity driven by growing demand for non-invasive therapeutic procedures. Market participants are investing in advanced imaging integration, precision targeting systems, and treatment optimization technologies to improve clinical outcomes. Expanding research initiatives focused on oncology and chronic disease management applications are also contributing to broader adoption and increased technological competitiveness in the sector.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| EDAP TMS S.A. (France) | |||||||
| Sonablate Corp. (United States) | |||||||
| Chongqing Haifu Medical Technology Co. Ltd. (China) | |||||||
| Theraclion SA (France) | |||||||
| Verasonics Inc. (United States) | |||||||
| ALPINION MEDICAL SYSTEMS Co. Ltd. (South Korea) | |||||||
| Profound Medical Corp. (Canada) | |||||||
| Insightec Ltd. (Israel) | |||||||
| ULTRAISER SAS (France). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Sonire Therapeutics | May-26 | Sonire Therapeutics secured $18 million in Series A funding to accelerate the clinical development and U.S. market entry of its high-intensity focused ultrasound (HIFU) platform for pancreatic cancer. This financing enables the company to advance its minimally invasive, outpatient treatment technology, marking a strategic step toward commercializing non-invasive therapeutic options for oncology patients with limited surgical alternatives. |
| Sonablate | May-26 | Sonablate launched the SONA FUSION global registry to centralize clinical data from international HIFU procedures. This initiative is designed to standardize real-world evidence, improve therapeutic protocols, and facilitate broader clinical adoption. By establishing a robust data-driven framework, the company aims to strengthen the long-term validation and market positioning of its high-intensity focused ultrasound technology within the urology segment. |
| Classys | Nov-25 | Classys acquired Brazil-based JL Health, a strategic move to strengthen its distribution network and market presence in South America. This acquisition enhances the company's ability to scale the international commercialization of its energy-based aesthetic medical devices, supporting a broader growth strategy centered on expanding its regulatory foothold and operational reach in key emerging global aesthetic markets. |
| Hoag | Apr-25 | The Hoag health system deployed new non-invasive ultrasound-based technology for the destruction of liver tumors. This operational expansion into advanced oncology applications highlights the increasing clinical utility of focused ultrasound in precision tumor ablation, reducing dependence on traditional surgical interventions and demonstrating the commercialization of sophisticated, image-guided therapeutic systems within large-scale hospital networks. |
| Avenda Health | Oct-24 | Avenda Health entered a strategic partnership with EDAP TMS to integrate robotic ultrasound systems with AI-driven treatment planning tools. This collaboration focuses on optimizing prostate cancer care by combining precision imaging and robotics, aiming to improve patient outcomes through more accurate, personalized ablation procedures and strengthening the competitive integration of digital technologies in minimally invasive oncology. |
| HistoSonics | Oct-23 | The FDA granted approval for HistoSonics' Edison platform, the first global regulatory authorization for a histotripsy-based system designed to noninvasively destroy liver tissue. This milestone establishes a significant new capability in the focused ultrasound market, representing a novel technological approach to tumor ablation and expanding the clinical landscape for energy-based, image-guided oncology procedures in the United States. |
| EDAP TMS | Jul-23 | Swiss authorities approved reimbursement for HIFU treatments of prostate cancer, providing a significant catalyst for clinical adoption and commercial scalability in the region. This policy shift supports EDAP TMS's strategy of expanding robotic energy-based therapy applications by reducing financial barriers to patient access, thereby reinforcing the company's long-term leadership position in minimally invasive, ultrasound-guided therapeutic technologies. |
| Profound Medical Inc. | Nov-20 | The FDA approved the Sonalleve MR-guided high-intensity focused ultrasound (MR-HIFU) system for treating osteoid osteoma in the extremities. By integrating high-intensity ablation with real-time temperature monitoring, this regulatory milestone established a new, non-invasive standard for orthopedic oncology applications, demonstrating the successful evolution and clinical validation of MRI-linked ultrasound technology for specialized, site-specific treatment. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
High Intensity Focused Ultrasound Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Treatment Approach | Ablation Therapy, Tissue Destruction, Pain Management, Neuromodulation |
| Technology Configuration | Standalone HIFU Systems, MRI-Guided HIFU Systems, Ultrasound-Guided HIFU Systems |
| Treatment Setting | Inpatient Facilities, Outpatient Facilities, Specialty Treatment Centers |
High Intensity Focused Ultrasound Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Clinical Adoption Pathway Analysis |
|
| Therapeutic Application Expansion |
|
| Reimbursement and Patient Access Strategy |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market size of high intensity focused ultrasound?
How is the high intensity focused ultrasound industry projected to perform over the next decade?
How is rising cancer prevalence influencing adoption of High Intensity Focused Ultrasound therapies?
How are expanding clinical applications beyond oncology shaping market adoption of HIFU technologies?
Why does Dermatology lead the high intensity focused ultrasound market?
Why is uterine fibroids emerging as the fastest-growing application?
Why does North America lead the high intensity focused ultrasound market?
How is Asia Pacific expanding in the high intensity focused ultrasound market?
Which organizations are considered leaders in the high intensity focused ultrasound landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization